Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Effectiveness of Ankle Foot Orthoses on Gait in Multiple Sclerosis [NA]
A terminated clinical trial at UT Southwestern evaluated the effectiveness of ankle-foot orthoses on gait in people with multiple sclerosis;…
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis [Phase 4]
Phase 4 follow-up study reporting long-term outcomes over 11 years for patients enrolled in the BENEFIT trial with a first demyelinating eve…
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Cytokine in Cerebrospinal Fluid (CSF) From Multiple Sclerosis Patients
The clinical trial evaluating a cytokine in the cerebrospinal fluid of patients with multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-07-17Clinical Trial Update: Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis [Phase 4]
A Phase 4 trial comparing lidocaine analgesia with extended-release oxycodone for neuropathic pain in multiple sclerosis was terminated, wit…
-
FDA approval · 2015-07-14FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for Tecfidera (dimethyl fumarate). This represents an approved update to the product's la…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Improving Gait in Multiple Sclerosis (MS) - Strength Training or Treadmill Walking? [NA]
A completed clinical trial sponsored by St. Olavs Hospital compared strength training versus treadmill walking to improve gait in people wit…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Robot-assisted Training of the Upper Limb in Persons With Multiple Sclerosis: an Randomized Controlled Trial [NA]
A completed randomized controlled trial evaluating robot-assisted training of the upper limb in persons with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Prospective, Multicenter Non Interventional Study to Evaluate Adherence to Betaferon Over a 2 Years Period
A prospective, multicenter non-interventional study evaluated adherence to Betaferon (interferon beta-1b) over two years in people with Mult…
-
CLINICAL_TRIALS research · 2015-07-03Clinical Trial Update: Comparison Between Clinical and MRI Multiple Sclerosis Activity and Expression of Human Endogenous Retrovirus Type W and Herpesvirus
An exploratory clinical trial update evaluating clinical and MRI activity in multiple sclerosis and the expression of human endogenous retro…
-
CLINICAL_TRIALS research · 2015-07-03Clinical Trial Update: D-mannose for the Prevention of UTIs in Multiple Sclerosis [Phase 1]
Phase 1 clinical trial examining D-mannose for prevention of urinary tract infections in patients with multiple sclerosis.
-
FDA approval · 2015-07-02FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GILENYA (fingolimod hydrochloride) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS research · 2015-06-30Clinical Trial Update: Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple Sclerosis
This clinical trial update evaluates the effects of dalfampridine (Fampyra) on gait, vision, cognition, fatigue, and bladder function in peo…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: TYSABRI Global Observational Program in Safety
Global observational safety program for TYSABRI (natalizumab) has completed.
-
FDA approval · 2015-06-16FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)
FDA approved Biogen's supplemental application for TECFIDERA (dimethyl fumarate), updating/authorizing changes to its labeling.
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis [Phase 2]
Biogen's BG00012 (dimethyl fumarate) Phase 2 combination trial in multiple sclerosis has completed, with results posted in June 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Multiple Sclerosis Rehabilitation Study [NA]
The clinical trial update notes the completion of Melbourne Health's rehabilitation study for individuals with Multiple Sclerosis.
-
FDA approval · 2015-06-01FDA Approved: MITOXANTRONE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for mitoxantrone hydrochloride, submitted by Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis [Phase 2]
A Phase 2 trial evaluating secukinumab (AIN457) for relapsing multiple sclerosis was terminated; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: The Effects of Ankle Foot Orthoses (AFOs) on Mobility in Persons With Multiple Sclerosis (MS) [NA]
A completed clinical trial evaluating the effects of ankle-foot orthoses on mobility in people with Multiple Sclerosis, with results posted …
-
FDA label_change · 2015-05-14FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GILENYA (fingolimod hydrochloride) from Novartis, resulting in changes to the product labeli…
-
CLINICAL_TRIALS trial_result · 2015-05-13Clinical Trial Update: Safety and Dose-finding Study of DC-TAB in Healthy Subjects [Phase 1]
Phase 1 safety and dose-finding study of DC-TAB in healthy subjects to assess safety and tolerability related to Multiple Sclerosis, sponsor…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor [Phase 3]
A Phase 3 trial evaluating botulinum toxin for disabling tremor in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Adderall XR and Processing Speed in Multiple Sclerosis (MS) [Phase 2, Phase 3]
Clinical trial update for Adderall XR evaluating processing speed in individuals with Multiple Sclerosis across Phase 2 and Phase 3; the stu…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial evaluating methylphenidate as a treatment option for fatigue in people with multiple sclerosis; current status is unk…
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis
Completed clinical trial evaluating modulation of plasmacytoid dendritic cell function in multiple sclerosis. Sponsor: Rutgers, The State Un…